Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Fuse, Nozomu
    Bando, Hideaki
    Chin, Keisho
    Ito, Seiji
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Terashima, Masanori
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Emi, Yasunori
    Yoshida, Kazuhiro
    Oki, Eiji
    Takahashi, Seiji
    Kuriki, Hiroshi
    Sato, Kumi
    Sasako, Mitsuru
    GASTRIC CANCER, 2017, 20 (02) : 332 - 340
  • [42] CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial
    Lu, Jun
    Xu, Bin-bin
    Zheng, Zhi-fang
    Xie, Jian-wei
    Wang, Jia-bin
    Lin, Jian-xian
    Chen, Qi-yue
    Cao, Long-long
    Lin, Mi
    Tu, Ru-hong
    Huang, Ze-ning
    Zheng, Chao-hui
    Huang, Chang-Ming
    Li, Ping
    GASTRIC CANCER, 2019, 22 (03) : 536 - 545
  • [43] Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy
    Oshima, Takashi
    Hashimoto, Itaru
    Hiroshima, Yukihiko
    Kimura, Yayoi
    Tanabe, Mie
    Nakayama, Yuta
    Nagasawa, Shinsuke
    Kanematsu, Kyohei
    Aoyama, Toru
    Yamada, Takanobu
    Ogata, Takashi
    Miyagi, Yohei
    ANTICANCER RESEARCH, 2024, 44 (10) : 4537 - 4542
  • [44] Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer
    Álvaro Díaz De Liaño
    Concepción Yarnoz
    Rubén Aguilar
    Cristina Artieda
    Héctor Ortiz
    Gastric Cancer, 2008, 11 : 96 - 102
  • [45] Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer
    De Liano, Alvaro Diaz
    Yarnoz, Concepcion
    Aguilar, Ruben
    Artieda, Cristina
    Ortiz, Hector
    GASTRIC CANCER, 2008, 11 (02) : 96 - 102
  • [46] A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy
    Shi, Litong
    Wang, Zehua
    Wang, Lei
    Jia, Yongxu
    Li, Jing
    Qin, Yanru
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 287 - 301
  • [47] Laparoscopic distal gastrectomy with D2 dissection for advanced gastric cancer
    Jiang Yu
    Yanfeng Hu
    Tao Chen
    Tingyu Mou
    Xia Cheng
    Guoxin Li
    Chinese Journal of Cancer Research, 2013, 25 (04) : 474 - 476
  • [48] Totally laparoscopic D2 radical distal gastrectomy for gastric cancer
    Yang, Guoshan
    Mou, Dongcheng
    Xu, Jianlin
    Wan, Binhua
    Zhang, Nengwei
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (05) : 380 - 382
  • [49] Laparoscopic distal gastrectomy with D2 dissection for advanced gastric cancer
    Yu, Jiang
    Hu, Yanfeng
    Chen, Tao
    Mou, Tingyu
    Cheng, Xia
    Li, Guoxin
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (04) : 474 - 476
  • [50] Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer
    Mizuno, Akira
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Iwata, Naoki
    Yamada, Suguru
    Fujii, Tsutomu
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    DIGESTIVE SURGERY, 2016, 33 (02) : 121 - 128